Janus Henderson Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
9,999
-523
-5% -$114K ﹤0.01% 1245
2025
Q1
$2.34M Buy
10,522
+730
+7% +$162K ﹤0.01% 1196
2024
Q4
$3.21M Sell
9,792
-434
-4% -$142K ﹤0.01% 1083
2024
Q3
$3.07M Hold
10,226
﹤0.01% 1093
2024
Q2
$3.37M Sell
10,226
-281
-3% -$92.5K ﹤0.01% 1011
2024
Q1
$4.15M Sell
10,507
-199
-2% -$78.7K ﹤0.01% 949
2023
Q4
$3.77M Buy
10,706
+842
+9% +$297K ﹤0.01% 937
2023
Q3
$3.7M Sell
9,864
-716
-7% -$269K ﹤0.01% 905
2023
Q2
$4.04M Sell
10,580
-1,256
-11% -$480K ﹤0.01% 922
2023
Q1
$4.1M Sell
11,836
-2,543
-18% -$881K ﹤0.01% 934
2022
Q4
$3.38M Buy
14,379
+4,609
+47% +$1.08M ﹤0.01% 957
2022
Q3
$2.41M Buy
9,770
+29
+0.3% +$7.14K ﹤0.01% 1217
2022
Q2
$2.95M Sell
9,741
-678,657
-99% -$206M ﹤0.01% 957
2022
Q1
$283M Sell
688,398
-190,464
-22% -$78.2M 0.14% 164
2021
Q4
$412M Buy
878,862
+262,999
+43% +$123M 0.17% 141
2021
Q3
$261M Buy
615,863
+46,003
+8% +$19.5M 0.11% 193
2021
Q2
$205M Sell
569,860
-77,619
-12% -$27.9M 0.09% 232
2021
Q1
$182M Sell
647,479
-40,094
-6% -$11.3M 0.08% 236
2020
Q4
$195M Buy
687,573
+15,631
+2% +$4.43M 0.09% 222
2020
Q3
$185M Buy
671,942
+43,155
+7% +$11.9M 0.1% 218
2020
Q2
$143M Sell
628,787
-227,236
-27% -$51.6M 0.08% 248
2020
Q1
$130M Sell
856,023
-92,403
-10% -$14.1M 0.09% 232
2019
Q4
$143M Sell
948,426
-9,105
-1% -$1.37M 0.07% 280
2019
Q3
$136M Buy
957,531
+41,266
+5% +$5.85M 0.07% 290
2019
Q2
$115M Sell
916,265
-45,987
-5% -$5.76M 0.06% 340
2019
Q1
$106M Buy
962,252
+46,338
+5% +$5.11M 0.06% 363
2018
Q4
$89.8M Buy
915,914
+39,109
+4% +$3.83M 0.06% 372
2018
Q3
$108M Buy
876,805
+1,082
+0.1% +$134K 0.06% 375
2018
Q2
$87M Buy
875,723
+186,752
+27% +$18.5M 0.05% 410
2018
Q1
$60.8M Buy
688,971
+66,513
+11% +$5.87M 0.04% 510
2017
Q4
$61.4M Buy
622,458
+113,227
+22% +$11.2M 0.04% 491
2017
Q3
$49M Buy
509,231
+315,115
+162% +$30.3M 0.03% 524
2017
Q2
$18.3M Buy
+194,116
New +$18.3M 0.01% 757